ClinicalTrials.gg
Drug

Dacarbazine clinical trials

Also written DTIC and DTIC-Dome.

studies test it
75
open now
10
in phase 3
16
first study started
1996

How each study uses Dacarbazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Dacarbazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 May 1975 · DTIC-DOME · NDA 017575 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dacarbazine
51
Dacarbazine (DTIC)
2
imidazole carboxamide
2
Biocarbazine
2

Brand

DTIC-Dome
6

Other names

DTIC
19
DIC
4

In one entry with another drug

Given together, or one or the other

ABVD
6

Studies by the year they started

73 studies that test it; most in 2007 (6); 1 more planned to start later

Studies that test Dacarbazine, by start year
YearStudies
19961
19971
19983
19992
20001
20011
20021
20032
20042
20053
20062
20076
20083
20094
20105
20114
20125
20132
20141
20151
20161
20175
20183
20193
20201
20211
20222
20231
20242
20254

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
51
Phase 3
16
Phase 4
2
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 61

University of Cologne (4) · M.D. Anderson Cancer Center (3) · Bristol-Myers Squibb (3) · Takeda (2) · City of Hope Medical Center (2) · Fondazione Italiana Linfomi - ETS (2) · University of Washington (2) · Eastern Cooperative Oncology Group (2)

Often tested with

Tested in the same studies.

Vinblastine (27) · Doxorubicin (25) · Brentuximab Vedotin (16) · Bleomycin (12) · Cisplatin (8) · Cyclophosphamide (7) · Etoposide (6) · Vincristine (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Dacarbazine is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 5, 1 in phase 3

Studies that test Dacarbazine, phase 3 first.

Studies

Open first, then newest update. How each study uses Dacarbazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 75

See all 75 studies that test Dacarbazine →

Given beside what is tested · 60 — Dacarbazine is usual care or a partner of the new treatment

Showing 20 of 60.

As the comparator · 34 — what is tested is compared with Dacarbazine

Showing 20 of 34.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Dacarbazine · ClinicalTrials.gg INT007295

  • MeSH (NLM) D003606DacarbazineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7GR28W0FJIDACARBAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 3098Confirmed FDA, Wikidata
  • Wikidata Q416975dacarbazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C411DacarbazineOne source FDA
  • DrugBank DB00851One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.